» Articles » PMID: 18704401

Staging of Untreated Nasopharyngeal Carcinoma with PET/CT: Comparison with Conventional Imaging Work-up

Overview
Date 2008 Aug 16
PMID 18704401
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: We prospectively compared PET/CT and conventional imaging for initial staging of nasopharyngeal carcinoma (NPC).

Methods: A total of 111 patients with histologically proven NPC were investigated with PET/CT and conventional imaging (head-and-neck MRI, chest X-ray, abdominal ultrasound, and bone scan) before treatment. The respective findings were reviewed independently and then compared with each other.

Results: With regard to T staging, PET/CT showed a discrepancy with head-and-neck MRI in 36 (32.4%) of the study subjects. With regard to N staging, PET/CT showed a discrepancy with head-and-neck MRI in 15 (13.5%) patients. Among the discordant cases, MRI was superior in demonstrating tumor involvement in the parapharyngeal space, skull base, intracranial area, sphenoid sinus, and retropharyngeal nodes while PET/CT was superior in demonstrating neck nodal metastasis. PET/CT disclosed 13 of 16 patients with distant malignancy compared with four patients disclosed by conventional imaging work-up. The false-positive rate of PET/CT was 18.8%. PET/CT correctly modified M staging in eight patients (7.2%) and disclosed a second primary lung malignancy in one patient (0.9%).

Conclusion: In NPC patients, MRI appears to be superior to PET/CT for the assessment of locoregional invasion and retropharyngeal nodal metastasis. PET/CT is more accurate than MRI for determining cervical nodal metastasis and should be the better reference for the neck status. PET/CT has an acceptable diagnostic yield and a low false-positive rate for the detection of distant malignancy and can replace conventional work-up to this aim. PET/CT and head-and-neck MRI are suggested for the initial staging of NPC patients.

Citing Articles

Advances in Nasopharyngeal Carcinoma Staging: from the 7th to the 9th Edition of the TNM System and Future Outlook.

Wu B, Chen X, Cao C Curr Oncol Rep. 2025; .

PMID: 39998781 DOI: 10.1007/s11912-025-01651-9.


Pretreatment FDG PET in prognosis of locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.

Niu X, Xue F, Ou D, Zheng Y, Hu C, Shen C Int J Med Sci. 2025; 22(4):933-939.

PMID: 39991768 PMC: 11843132. DOI: 10.7150/ijms.105995.


Intravertebral collateral enhancement resembling sclerotic metastatic disease in a case of cervical epidural abscess.

Schneider D, Ok A, Simpfendorfer C, Forney M, Subhas N Skeletal Radiol. 2024; .

PMID: 39080030 DOI: 10.1007/s00256-024-04761-w.


Comparison of [F]FDG and [ Ga]pentixafor PET/CT in Nasopharyngeal Carcinoma.

Liu M, Chen X, Ding H, Shu Q, Zheng Y, Chen Y Mol Imaging Biol. 2024; 26(4):658-667.

PMID: 38627276 DOI: 10.1007/s11307-024-01913-1.


Prognostic value of lymph node-to-primary tumor ratio of PET standardized uptake value for nasopharyngeal carcinoma: a recursive partitioning risk stratification analysis.

Kong F, Pan G, Ni M, Du C, Hu C, Ying H Ther Adv Med Oncol. 2024; 16:17588359241233235.

PMID: 38379851 PMC: 10878206. DOI: 10.1177/17588359241233235.


References
1.
Chen Y, Su C, Ding H, Chi K, Liang J, Shen Y . Clinical usefulness of fused PET/CT compared with PET alone or CT alone in nasopharyngeal carcinoma patients. Anticancer Res. 2006; 26(2B):1471-7. View

2.
Liu F, Chang J, Wang H, Liao C, Kang C, Ng S . [18F]fluorodeoxyglucose positron emission tomography is more sensitive than skeletal scintigraphy for detecting bone metastasis in endemic nasopharyngeal carcinoma at initial staging. J Clin Oncol. 2006; 24(4):599-604. DOI: 10.1200/JCO.2005.03.8760. View

3.
Righi P, Kopecky K, Caldemeyer K, Ball V, Weisberger E, RADPOUR S . Comparison of ultrasound-fine needle aspiration and computed tomography in patients undergoing elective neck dissection. Head Neck. 1997; 19(7):604-10. DOI: 10.1002/(sici)1097-0347(199710)19:7<604::aid-hed7>3.0.co;2-b. View

4.
Antoch G, Saoudi N, Kuehl H, Dahmen G, Mueller S, Beyer T . Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol. 2004; 22(21):4357-68. DOI: 10.1200/JCO.2004.08.120. View

5.
Lardinois D, Weder W, Hany T, Kamel E, Korom S, Seifert B . Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med. 2003; 348(25):2500-7. DOI: 10.1056/NEJMoa022136. View